Avera Cancer Institute- Mitchell — Mitchell, South Dakota

Avera Cancer Institute- Mitchell is a clinical research site located in Mitchell, South Dakota, United States 57301.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Avera Cancer Institute- Mitchell has participated in 15 clinical trials with 15 currently active.

Therapeutic areas: Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Mitchell

Browse all research sites in South Dakota · View every site in Mitchell

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Avera Cancer Institute- Mitchell?

Avera Cancer Institute- Mitchell has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Avera Cancer Institute- Mitchell conducted?

Avera Cancer Institute- Mitchell has 15 clinical trials on record, with 15 currently active. Their work covers Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma.

Is Avera Cancer Institute- Mitchell accredited by Crixeo Clinical Trials?

Avera Cancer Institute- Mitchell has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Avera Cancer Institute- Mitchell?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.